4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001562180-18-002166
Options or other derivatives
- President, Diagnostics & Genom acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kelderman Kim · President, Diagnostics & Genom
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-01 | Grant or award : show line 1 in the form Restricted Stock | +5,000 | 5,000 | D |
| 2018-05-01 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +2,652 | 2,652 | D |
| 2018-05-01 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +7,348 | 10,000 | D |
Loading xslF345X03/primarydocument.xml…